OncoSec Medical to Present New Clinical Data at Melanoma Bridge 2014

OncoSec Medical Inc. , a company developing DNA-based intratumoral cancer immunotherapies, will present new data from clinical studies evaluating the Company’s ImmunoPulse immunotherapy in patients with melanoma at Melanoma Bridge 2014.



from Content Keyword RSS http://ift.tt/1EhRgbD

via IFTTT